When clinical studies demonstrated that GLP1 drugs (e.g., semaglutide, tirzepatide), developed to treat diabetes, are effective weight loss drugs that directly act on the brains satiety center to reduce food intake (also drink less alcohol and smoke fewer cigarettes) doctors began prescribing them to help reduce the health risks associated with obesity
Additionally, combination therapy is becoming more common
So when we look at this, when we look at it through the lens, what you were asking me about with long Covid, with MCAS, etc
In cases of NAION caused by a medication, questions may arise about whether patients were sufficiently informed of this rare but serious risk
Our Crave Curb Complex acts as a premium appetite suppressant, using 5-HTP and Green Tea Extract to promote a feeling of fullness
The most successful of these was a letter outreach pilot where Hispanic patient enrollment rates improved from 25% to 48%